about
Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer.Erratum to: A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors.Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
P50
Q34431008-09DA73D1-2BB6-427D-93BC-B65BDC207568Q35813037-1554D8D3-C8D1-4228-9C4E-2EF03E7F9C04Q36850925-56D2F774-E949-4E40-B1B4-2BC78304DD33Q38719706-E1FAA5A1-CD1B-4503-8A0F-C591EE89B339Q42780572-C194EAA8-1F26-47B5-87F6-D6AE510E0D25Q47862291-25C32308-31B7-4B54-BD74-CFB9C3D816B7Q48023073-C3F5A6EA-3BE3-465F-B020-8FCB8A8CF1D4
P50
description
researcher, ORCID id # 0000-0002-6843-0280
@en
wetenschapper
@nl
name
Sue H Lee
@ast
Sue H Lee
@en
Sue H Lee
@es
Sue H Lee
@nl
type
label
Sue H Lee
@ast
Sue H Lee
@en
Sue H Lee
@es
Sue H Lee
@nl
prefLabel
Sue H Lee
@ast
Sue H Lee
@en
Sue H Lee
@es
Sue H Lee
@nl
P106
P1153
56413329000
P31
P496
0000-0002-6843-0280